Lpl Financial LLC Nektar Therapeutics Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Lpl Financial LLC holds 65,750 shares of NKTR stock, worth $70,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,750

Previous 49,290 33.39%

Holding current value

$70,352

Previous $61,000 39.34%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.11 - $1.48 $18,270 - $24,360	16,460 Added 33.39%	65,750 $85,000
Q2 2024 Aug 07, 2024	BUY	$0.9 - $1.83 $12,417 - $25,248	13,797 Added 38.87%	49,290 $61,000
Q1 2024 May 10, 2024	SELL	$0.49 - $0.96 $6 - $12	-13 Reduced 0.04%	35,493 $33,000
Q3 2023 Nov 13, 2023	BUY	$0.51 - $1.05 $12,801 - $26,355	25,100 Added 241.21%	35,506 $21,000
Q2 2023 Jul 31, 2023	SELL	$0.53 - $1.03 $26 - $51	-50 Reduced 0.48%	10,406 $6,000
Q1 2023 May 10, 2023	BUY	$0.64 - $3.15 $18 - $91	29 Added 0.28%	10,456 $7,000
Q4 2022 Feb 07, 2023	SELL	$2.03 - $4.28 $21,416 - $45,154	-10,550 Reduced 50.29%	10,427 $23,000
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $483 - $817	159 Added 0.76%	20,977 $67,000
Q2 2022 Aug 12, 2022	SELL	$3.17 - $6.17 $35,348 - $68,801	-11,151 Reduced 34.88%	20,818 $79,000
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $3,319 - $10,948	-798 Reduced 2.44%	31,969 $172,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $20,956 - $35,623	1,935 Added 6.28%	32,767 $443,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $16,991 - $24,492	-1,300 Reduced 4.05%	30,832 $554,000
Q2 2021 Aug 13, 2021	BUY	$16.52 - $20.4 $10,523 - $12,994	637 Added 2.02%	32,132 $551,000
Q1 2021 May 14, 2021	BUY	$16.56 - $25.46 $8,031 - $12,348	485 Added 1.56%	31,495 $630,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $82,287 - $99,298	5,218 Added 20.23%	31,010 $527,000
Q3 2020 Nov 09, 2020	SELL	$16.59 - $24.79 $35,834 - $53,546	-2,160 Reduced 7.73%	25,792 $428,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $49,433 - $68,726	2,932 Added 11.72%	27,952 $647,000
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $48,908 - $94,504	3,380 Added 15.62%	25,020 $447,000
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $34,088 - $49,661	2,148 Added 11.02%	21,640 $467,000
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $71,766 - $153,929	-4,244 Reduced 17.88%	19,492 $355,000
Q2 2019 Aug 09, 2019	SELL	$31.0 - $36.3 $26,691 - $31,254	-861 Reduced 3.5%	23,736 $845,000
Q1 2019 May 08, 2019	BUY	$31.58 - $46.35 $176,595 - $259,189	5,592 Added 29.42%	24,597 $826,000
Q4 2018 Feb 07, 2019	BUY	$30.43 - $56.65 $405,692 - $755,257	13,332 Added 235.01%	19,005 $625,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $12,079 - $17,807	260 Added 4.8%	5,673 $346,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $94,026 - $212,346	2,033 Added 60.15%	5,413 $264,000
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $194,012 - $366,527	3,380 New	3,380 $359,000

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Nektar Therapeutics Transaction History